carbenoxolone sodium has been researched along with bumetanide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Hao, B; Huang, JL; Li, XY; Ma, AN; Pertovaara, A; Wang, YX; Wei, H | 1 |
3 other study(ies) available for carbenoxolone sodium and bumetanide
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Intrathecal administration of a gap junction decoupler, an inhibitor of Na(+)-K(+)-2Cl(-) cotransporter 1, or a GABA(A) receptor agonist attenuates mechanical pain hypersensitivity induced by REM sleep deprivation in the rat.
Topics: Animals; Behavior, Animal; Bumetanide; Carbenoxolone; Chloride Channels; GABA Agonists; Gap Junctions; Hyperalgesia; Injections, Spinal; Microglia; Microinjections; Minocycline; Muscimol; Pain Measurement; Psychomotor Performance; Rats; Rats, Wistar; Receptors, GABA-A; Sleep Deprivation; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2 | 2010 |